Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMY53PL)

Drug Name	GW 597599 DMY53PL
Synonyms	Vestipitant mesylate < USAN; N-[1(R)-[3,5-Bis(trifluoromethyl)phenyl]ethyl]-2(S)-(4-fluoro-2-methylphenyl)-N-methylpiperazine-1-carboxamide methanesulfonate
Drug Type	Small molecular drug
Structure
Structure	3D MOL is unavailable			2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Mood disorder	DISLVMWO	6A60-6E23	Phase 2	[1]
Major depressive disorder	DIS4CL3X	6A70.3	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015473)
2	ClinicalTrials.gov (NCT01507194) A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV). U.S. National Institutes of Health.